1. Home
  2. JFB vs QNCX Comparison

JFB vs QNCX Comparison

Compare JFB & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JFB
  • QNCX
  • Stock Information
  • Founded
  • JFB 2014
  • QNCX 2012
  • Country
  • JFB United States
  • QNCX United States
  • Employees
  • JFB N/A
  • QNCX N/A
  • Industry
  • JFB
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • JFB
  • QNCX Health Care
  • Exchange
  • JFB NYSE
  • QNCX Nasdaq
  • Market Cap
  • JFB 49.5M
  • QNCX 47.7M
  • IPO Year
  • JFB 2025
  • QNCX 2019
  • Fundamental
  • Price
  • JFB $5.31
  • QNCX $1.31
  • Analyst Decision
  • JFB
  • QNCX Strong Buy
  • Analyst Count
  • JFB 0
  • QNCX 5
  • Target Price
  • JFB N/A
  • QNCX $8.00
  • AVG Volume (30 Days)
  • JFB 26.8K
  • QNCX 304.4K
  • Earning Date
  • JFB 08-11-2025
  • QNCX 08-12-2025
  • Dividend Yield
  • JFB N/A
  • QNCX N/A
  • EPS Growth
  • JFB N/A
  • QNCX N/A
  • EPS
  • JFB 0.00
  • QNCX N/A
  • Revenue
  • JFB $25,946,544.00
  • QNCX N/A
  • Revenue This Year
  • JFB N/A
  • QNCX N/A
  • Revenue Next Year
  • JFB N/A
  • QNCX N/A
  • P/E Ratio
  • JFB $1,367.53
  • QNCX N/A
  • Revenue Growth
  • JFB N/A
  • QNCX N/A
  • 52 Week Low
  • JFB $3.39
  • QNCX $0.51
  • 52 Week High
  • JFB $6.50
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • JFB N/A
  • QNCX 64.64
  • Support Level
  • JFB N/A
  • QNCX $1.29
  • Resistance Level
  • JFB N/A
  • QNCX $1.45
  • Average True Range (ATR)
  • JFB 0.00
  • QNCX 0.09
  • MACD
  • JFB 0.00
  • QNCX 0.03
  • Stochastic Oscillator
  • JFB 0.00
  • QNCX 76.74

About JFB JFB CONSTRUCTION HOLDINGS

JFB Construction Holdings is a commercial and residential real estate construction and development company. It is engaged in retail corporate buildouts, multifamily community developments and luxury residential homes, with a focus on fostering long-term relationships with clients, partners, and communities. The company operates in three distinct business segments: Commercial Construction, Residential Construction, and Real Estate Development. Key revenue is generated from Commercial Construction: This segment includes all activities related to the construction of commercial properties such as office buildings, retail spaces, and industrial facilities.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: